Tuesday, 14 October 2025
  
Login

Australia's most trusted
source of pharma news

Tuesday, 14 October 2025
News

Trump bags second pharma deal

Posted 13 October 2025 PM

US President Donald Trump has bagged his second price-cutting deal with a pharma company, announcing an agreement with British giant, AstraZeneca, resulting in "hundreds of millions of dollars" in savings.

Under the Most Favoured Nation (MFN) deal, AstraZeneca will provide every State Medicaid program in the US with drugs priced in line with the lowest paid by other developed nations. It is the second company to sign up to the deal, with Pfizer starting the ball rolling two weeks ago.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (24)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (1)

Devices (1)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.